References
- Pizzo PA. Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient. J Pediatr 1981; 98: 341–54.
- Louria DB. Controversies in the management of the infectious complications of neoplastic disease. Introduction and epidemiology. Am J Med 1984; 76: 414–20.
- Bodey gP. Infection in cancer patient. A continuing association. Am J Med 1986; 81 (supp 1A): 11–26.
- Shenep JL, Hughes WT, Roberson PK et al. Vancomycin, ticarcillin and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med 1988; 319: 1053–8.
- Wade JC, Schimpff SC, Newman KA, Fortner CL, Standifort HC, Wiernik PH. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients. Am J Med 1981; 71: 983–90.
- Brown AE. Management in the febrile, neutropenic patient with cancer: therapeutic considerations. J Pediatr 1985; 106: 1035–41.
- Stefani S, Castiglia P, Maida A, Muresu E, Mezzatesta ML, Nicoletti g. Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates. J Chemother 1990; 2: 295–9.
- Lawson RD, gentry LO, Bodey GP et al. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies. Am J Med Sci 1984; 287: 16–23.
- The EORTC International Antimicrobial Therapy Cooperative group: Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317: 1692–8.
- Reiner R, eds. Antibiotics, An Introduction. Stuttgart: Roche, 1972: 67.
- Donowitz GR, Mandell GL. Beta-lactam antibiotics. N Engl J Med 1988; 318: 419.
- Gedikoğlu g, Ağaoğlu L, Devecioğlu Ö, Anak S, Sağlam. A randomized study on antibiotic combinations used for the empiric treatment of 89 neutropenic febrile children with oncologic diseases. In: Berkade B, Kuemmerle MP eds. Progress in Antimicrobial and Anticancer Chemotherapy: Landsberg/Lech: Ecomed, 1987: 603–4.
- Meunier F, Aoun M, Gerard M. Therapy for oropharyngeal candidiasis in the immunocompromised host: A randomized double blind study of fluconazole vs ketokonazole. Rev Infect Dis 1990; 12 (suppl 3): 364–8.
- Edward JE. Invasive candida infection, evaluation of a fungal pathogen. N Engl J Med 1991; 324: 1060–2.
- Levis JH, Zimmerman HJ, Benson GD, Ishak KG. Hepatic injury associated with ketoconazole therapy: Analysis of 33 cases. Gastroenterology 1984; 86: 503–13.
- Macnair AL, Gascoigne E, Heap J, Schuermans V, Symoens J. Hepatitis and ketoconazole therapy. Br Med J 1981; 283: 1058.